EcoDrugPlus

Ensembl ID : ENSUAMG00000017670
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSUAMG00000003484
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSUAMG00000003339
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSUAMG00000002887
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSUAMG00000002601
Gene Symbol: -
Cross references: -
420 Possible Orthologues:

Ensembl ID : ENSUAMG00000000882
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSUAMG00000000518
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSUAMG00000016795
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSUAMG00000000402
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSUAMG00000000293
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSUAMG00000018255
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSUAMG00000023003
Gene Symbol: -
Cross references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).